US-based Lonestar Films sign Sharib Hashmi, Aahna Kumra for Cancer

0
- ADVERTISEMENT -
Eminent character artiste Sharib Hashmi plays the male lead in Lonestar Films’ maiden Hindi film, Cancer. Photo: ITAI Doshin Media

The US-based entertainment production house, Lonestar Films, forays into India with their maiden full-length Hindi feature film, titled Cancer. Sharib Hashmi and Aahna Kumra play the lead roles. Incorporated in the USA, Lonestar Films is promoted by Pankaj Mamtora, who is a serial entrepreneur with business interests also in healthcare, pharmaceuticals, fitness and real estate.

The film will be directed by Faisal Hashmi who is making his Hindi debut and is known for Gujarati language films like Vitamin She and the award-winning Short Circuit.

Touted as ‘a mind-bending futuristic thriller’, Cancer is in pre-production and will go on the floors early next year. The hunt for the other two lead actors is underway. Sources say the film will be a visually-luxurious thriller and the rest of the cast will be locked by the year end.

Speaking about the film, Sharib Hashmi said, “The narration got me totally gobsmacked. I did not gauge what was coming and was on tenterhooks all through it. I have not seen anything like this on Indian screens and I genuinely believe that the script is our hero. I hope to do my very best to match up. Faisal is a man of few words and through our discussion he has already given me a lot of creative liberty to approach the character.”

Faisal Hashmi, director, added, “I have stayed with the film for a very long time, and now that it is about to take off, it almost feels surreal. I am extremely grateful to Pankaj, Devansh and Sharib for showing faith in the script and I hope the film brings a lot of fulfillment to everyone associated with the project.”

Lonestar Films has already set up operations in Mumbai, hiring Devansh Patel as its Chief Creative Officer. Patel will handle the creative mandates alongside the project directors and will oversee India operations.

 

Share

LEAVE A REPLY

Please enter your comment!
Please enter your name here